Please Wait.....
Report
Europe Cell & Gene Therapy Market - Focused Insights 2024-2029
Market Report I 2024-06-05 I 103 Pages I Arizton Advisory & Intelligence
The Europe cell and gene therapy market is expected to grow at a CAGR of 36.26% from 2023 to 2029.
MARKET DRIVERS
Funding Support in Europe for CGTs: US companies have primarily driven the growth of investments in CGT projects in recent years. The US market saw a 53% increase in CGT investment in 2021 compared to the previous year, while Europe experienced an 8% loss of funding. For European CGT development to keep up with global trends, additional funds are required to compensate for the loss in investment from 2021. More collaboration and investment from the European pharmaceutical market into academic research projects in CGTs are needed. Governments, including CGTs, can drive such collaborations and further investment to increase their position in the biopharma market. These initiatives can affect more private investment and talent in Europe, creating conditions needed to turn the European CGT market around.
Rising use of CGT Products for Disease Care: Cell & gene therapy solutions treat various diseases. They help to diagnose diseases by replacing, inactivating, and introducing genes into the body. Cell & gene therapy has a different way of treating diseases. Some of the biggest strides in cell & gene therapy are in the field of oncology, leading to targeted, personalized treatments that positively influence the market growth. Different technologies and customized treatments have driven the demand for cell & gene therapy solutions over the last few decades. In disease diagnosis, cell therapies are mainly used for cancer, diabetes, genetic disorders, musculoskeletal diseases, eye disorders, and other diseases. As per the Medicine in Development report, there are around 250+ products in the development stage for a broad range of diseases.
EUROPE CELL AND GENE THERAPY MARKET INSIGHTS
- By product, in 2023, the gene therapy segment occupied the largest share of the Europe cell and gene therapy market. The growing research in gene therapy techniques and development is expected to boost market growth. The increasing application of gene therapies in disease diagnosis, rising funding for gene therapies in small and medium-sized manufacturing companies, and the rapid increase in new drug applications will create new market space in the upcoming years.
- The oncology application segment showcases significant growth, with the fastest-growing CAGR of over 38% during the forecast period. The high success rate of cell and gene therapy solutions against cancer, the high application rate of cell and gene therapy products on various cancers, and the high investment and rapidly increasing development in oncology regenerative medicines drive the growth of this segment.
- The hospital end-user segment. The increasing collaboration and partnerships between manufacturers and hospitals, the shift from traditional hospital environments to gene therapy production, the growing demand for advanced therapy medicine products over traditional treatments, and revenue generation opportunities for health systems, including in-house cell and gene therapy manufacturing, are major factors fueling the growth of the hospital segment in the cell and gene therapy market.
SEGMENTATION & FORECAST BY
- Product
o Gene Therapy
o Cell Therapy
- Application
o Oncology
o Genetic Disorders
o Dermatology
o Musculoskeletal
o Others
- End-user
o Hospitals
o Cancer Care Centers
o Others
REGIONAL ANALYSIS
Germany held the largest share, over 21%, in the European cell and gene therapy market in 2023. Germany is at the forefront of cell and gene therapy due to major investments by the public and private sectors, which have boosted the development of the country's cell and gene therapy market. Germany is actively developing and testing innovative cell and gene therapy medicines, which offer patients vast benefits.
- Region
o Germany
o France
o UK
o Spain
o Italy
o Rest of Europe
VENDOR LANDSCAPE
The Europe cell and gene therapy market report includes exclusive data on 36 vendors. The Europe cell & gene therapy market is highly competitive, driven by the increasing number of biopharmaceutical companies developing new therapies. Moreover, the rising financial support and government initiatives for regenerative medicines and advanced medicinal products boost key players in the market. Leading market players in the Europe CGT market are Novartis, Gilead Sciences, Amgen, F. Hoffmann-La Roche, Orchard Therapeutics, BioMarin Pharmaceutical, PTC Therapeutics, Bristol-Myers Squibb, Organogenesis, Smith & Nephew, Legend Biotech, CSL Ltd, Vertex Pharmaceuticals Inc, and Human Stem Cells Institute PJSC, which are competing with rapidly emerging market players in the market. Vendors in the market are increasing their market share through inorganic growth.
Key Vendors
- Novartis
- Gilead Sciences
- Amgen
- F. Hoffmann-La Roche
- Orchard Therapeutics
- BioMarin Pharmaceutical
- PTC Therapeutics
- Bristol-Myers Squibb
- Organogenesis
- Smith & Nephew
- Legend Biotech
- CSL Ltd
- Vertex Pharmaceuticals Inc
- Human Stem Cells Institute PJSC
Other Prominent Vendors
- CHIESI Farmaceutici
- CollPlant
- CO.DON
- Takeda Pharmaceutical Company
- Nipro
- Vericel
- Avita Medical
- GenSight
- AGC Biologics
- Atara Biotherapeutics Inc
- NuVasive
Key Emerging Vendors
- Adaptimmune Therapeutics
- AgenTus Therapeutics
- Autolus Therapeutics
- Cellectis
- Celyad
- CombiGene AB
- Eukarys
- FREELINE Therapeutics
- Innoskel
- Psioxus Therapeutics
- Sparing Vision
KEY QUESTIONS ANSWERED:
1. Who are the major Europe cell and gene therapy market players?
2. Which region dominates the Europe cell and gene therapy market?
3. What are the Europe cell and gene therapy market trends?
4. What is the growth rate of the Europe cell and gene therapy market?
5. How big is the Europe cell and gene therapy market?
CHAPTER - 1: Cell & Gene Therapy Market Overview
- Executive Summary
- Key Findings
CHAPTER - 2: Cell & Gene Therapy Market
- Europe: Projected Revenue of Cell & Gene Therapy Market (2024-2029; $Billions)
CHAPTER - 3: Cell & Gene Therapy Market Segmentation Data
- Europe: Projected Revenue by Product (2024-2029; $Billions)
o Gene Therapy
o Cell Therapy
- Europe: Projected Revenue by Application (2024-2029; $Billions)
o Oncology
o Genetic Disorders
o Dermatology
o Musculoskeletal
o Others
- Europe: Projected Revenue by End-user (2024-2029; $Billions)
o Hospitals
o Cancer Care Centers
o Others
CHAPTER - 4: Key Countries Overview
- Projected Revenue of Cell & Gene Therapy Market in Germany
- Projected Revenue of Cell & Gene Therapy Market in France
- Projected Revenue of Cell & Gene Therapy Market in UK
- Projected Revenue of Cell & Gene Therapy Market in Spain
- Projected Revenue of Cell & Gene Therapy Market in Italy
- Projected Revenue of Cell & Gene Therapy Market in ROEU
CHAPTER - 5: Cell & Gene Therapy Market Prospects & Opportunities
- Cell & Gene Therapy - Market Opportunities & Trends
- Cell & Gene Therapy - Market Drivers
- Cell & Gene Therapy - Market Constraints
CHAPTER - 6: Cell & Gene Therapy Industry Overview
- Cell & Gene Therapy Market - Competitive Landscape
- Cell & Gene Therapy Market - Key Vendor Profiles
- Cell & Gene Therapy Market - Other Prominent Vendors
- Cell & Gene Therapy Market - Key Strategic Recommendations
CHAPTER - 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton
LIST OF EXHIBITS
Exhibit 1: Projected Revenue of CGT in Europe (2020-2029; $ Bn)
Exhibit 2: Market Size & Forecast - Gene Therapy (2020-2029; $ Bn)
Exhibit 3: Market Size & Forecast - Cell Therapy (2020-2029; $ Bn)
Exhibit 4: Market Size & Forecast - Oncology (2020-2029; $ Bn)
Exhibit 5: Market Size & Forecast - Genetic Disorders (2020-2029; $ Bn)
Exhibit 6: Market Size & Forecast - Dermatology (2020-2029; $ Bn)
Exhibit 7: Market Size & Forecast - Musculoskeletal (2020-2029; $ Bn)
Exhibit 8: Market Size & Forecast - Others (2020-2029; $ Bn)
Exhibit 9: Market Size & Forecast - Hospitals (2020-2029; $ Bn)
Exhibit 10: Market Size & Forecast - Cancer Care Centers (2020-2029; $ Bn)
Exhibit 11: Market Size & Forecast - Other End-users (2020-2029; $ Bn)
Exhibit 12: Market Size & Forecast - Germany (2020-2029; $ Bn)
Exhibit 13: Market Size & Forecast - France (2020-2029; $ Bn)
Exhibit 14: Market Size & Forecast - UK (2020-2029; $ Bn)
Exhibit 15: Market Size & Forecast - Spain (2020-2029; $ Bn)
Exhibit 16: Market Size & Forecast - Italy (2020-2029; $ Bn)
Exhibit 17: Market Size & Forecast - ROEU (2020-2029; $ Bn)
LIST OF TABLES
Table 1: Key Market Trends in Cell & Gene Therapy Market
Table 2: Key Market Enablers in Cell & Gene Therapy Market
Table 3: Key Market Constraints in Cell & Gene Therapy Market
Table 4: Strategic Recommendations in Cell & Gene Therapy Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security